Janney Montgomery Scott
MYGN icon

Janney Montgomery Scott’s Myriad Genetics MYGN Stock Holding History

Janney Montgomery Scott’s Portfolio MYGN Stock Details MYGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		– Sell
-132,213
Closed -$956K – 2984
2025
Q3 		$956K Sell
132,213
-31,378
-19% -$186K ﹤0.01% 1722
2025
Q2 		$869K Buy
+163,591
New +$966K ﹤0.01% 1670

Other funds holding MYGN

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
GCM
Glenview Capital Management New York $5.49B AUM 46.89% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $27.8B AUM 46.46% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Janney Montgomery Scott's MYGN Position: Q4 2025 in Review

Janney Montgomery Scott sold out of Myriad Genetics (MYGN) in Q4 2025, closing a stake of 132,213 shares — an estimated $956K sold.

Janney Montgomery Scott first reported a position in MYGN in Q2 2025 and held it in 2 quarters. The position peaked at $956K in Q3 2025. 221 funds tracked by Wall St. Rank hold MYGN as of Q4 2025.

  • Janney Montgomery Scott reported no remaining Myriad Genetics position as of Q4 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 132,213 Myriad Genetics shares in Q4 2025, an estimated $956K.
  • Janney Montgomery Scott first reported a position in Myriad Genetics in Q2 2025 and held it in 2 quarters.
  • Janney Montgomery Scott's Myriad Genetics position peaked at $956K in Q3 2025.
  • 221 funds tracked by Wall St. Rank held Myriad Genetics as of Q4 2025.

Based on Janney Montgomery Scott's 13F filing for Q4 2025, filed 11 Feb 2026.